Author:
Wang Jihong,Yi Hong,Li Juxiang,Yang Yuting,Sun Guofang,Xue Yumei,He Ling
Funder
National Natural Science Foundation of China
Jiangxi Provincial Natural Science Foundation
Reference31 articles.
1. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy;Chen;Biomed. Pharmacother.,2022
2. Long-term follow-up of the response-adjusted therapy for advanced Hodgkin lymphoma trial;Luminari;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2023
3. A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis;Guo;Inflammopharmacology,2023
4. Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy;Sun;Front. Pharmacol.,2023
5. Cell death regulation in myocardial toxicity induced by antineoplastic drugs;Yu;Front. Cell Dev. Biol.,2023